Danaher net earnings increase 9% to $597 million in Q3 2013

Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to increases in financial metrics reflect year-over-year changes, unless otherwise noted.

For the quarter ended September 27, 2013, net earnings were $597.0 million, or $0.84 per share on a diluted basis, a 9.0% increase. Revenues increased 5.5% to $4.7 billion with core revenues increasing 3.0%.

The Company anticipates that GAAP diluted net earnings per share for the quarter ending December 31, 2013 will be in the range of $0.91 to $0.96.  The Company reaffirmed its full year 2013 adjusted diluted net earnings per share guidance of $3.37 to $3.42.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, "Our team has continued to execute well using the Danaher Business System to deliver solid core revenue growth, operating margin expansion and cash flow performance in the quarter. Our new product development and go-to-market investments are driving relative outperformance in many of our businesses.  We believe our focus on accelerating our growth spending and our productivity and efficiency initiatives, combined with our optimism on the acquisition front, position us well for the balance of 2013 and beyond."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2019, June 19). Danaher net earnings increase 9% to $597 million in Q3 2013. News-Medical. Retrieved on April 23, 2024 from https://www.news-medical.net/news/20131017/Danaher-net-earnings-increase-925-to-24597-million-in-Q3-2013.aspx.

  • MLA

    Danaher. "Danaher net earnings increase 9% to $597 million in Q3 2013". News-Medical. 23 April 2024. <https://www.news-medical.net/news/20131017/Danaher-net-earnings-increase-925-to-24597-million-in-Q3-2013.aspx>.

  • Chicago

    Danaher. "Danaher net earnings increase 9% to $597 million in Q3 2013". News-Medical. https://www.news-medical.net/news/20131017/Danaher-net-earnings-increase-925-to-24597-million-in-Q3-2013.aspx. (accessed April 23, 2024).

  • Harvard

    Danaher. 2019. Danaher net earnings increase 9% to $597 million in Q3 2013. News-Medical, viewed 23 April 2024, https://www.news-medical.net/news/20131017/Danaher-net-earnings-increase-925-to-24597-million-in-Q3-2013.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Molecular Devices brand re-launched into life sciences marketplace